Callitas Health Inc. Share Price

Equities

MPHMF

CA13125C1068

Biotechnology & Medical Research

Delayed OTC Markets 15:05:17 01/03/2024 GMT 5-day change 1st Jan Change
0.0001 USD +9,900.00% Intraday chart for Callitas Health Inc. -.--% +9,900.00%
Sales 2018 0.75 59.83 Sales 2019 0.71 56.56 Capitalization 3.53M 281M
Net income 2018 -5M -399M Net income 2019 -1M -79.76M EV / Sales 2018 4,852,616 x
Net Debt 2018 319K 25.44M Net Debt 2019 848K 67.61M EV / Sales 2019 6,168,166 x
P/E ratio 2018
-0.6 x
P/E ratio 2019
-1.97 x
Employees -
Yield 2018 *
-
Yield 2019
-
Free-Float 72.04%
More Fundamentals * Assessed data
Dynamic Chart
1 day+9,900.00%
6 months-99.23%
More quotes
Current year
0.00
Extreme 0.0001
0.00
1 year
0.00
Extreme 0
0.00
3 years
0.00
Extreme 0
0.04
5 years
0.00
Extreme 0
0.15
10 years
0.00
Extreme 0
3.50
More quotes
Managers TitleAgeSince
Chief Executive Officer - 02/01/18
Director of Finance/CFO 42 -
Director/Board Member 47 -
Members of the board TitleAgeSince
Director/Board Member 69 30/11/14
Director/Board Member - -
Director/Board Member 47 -
More insiders
Callitas Health Inc is a Canada-based company that is primarily engaged in integrated clinical-stage pharmaceutical development and over-the-counter (OTC) consumer goods marketing. The Company provides biomedical technologies and products. The Company offers drug treatments for obesity, infertility, intimacy issues, weight management, female sexual dysfunction solutions and women wellness.
More about the company